News & events

Study gets under way to test psilocybin for treatment-resistant depression

The NIHR-Wellcome Trust King's Clinical Research Facility has administered psilocybin to a patient with treatment-resistant depression in the first randomised controlled trial of its kind.

By Administrator at 17 Sep 2019

Medichec: A tool to make prescribing safer for people with dementia

Dr Justin Sauer is a Consultant Psychiatrist and Clinical Lead for Memory Services in Older Adult Services in SLaM and co-founder of Medichec

By Dr Justin Sauer at 10 Sep 2019

Six BRC academics promoted to new positions, including two new professorships

The BRC is delighted to announce that six of its researchers have been promoted, with their new academic positions coming into effect this month.

By Administrator at 10 Sep 2019

Inspiring the next generation: budding young scientists go behind the scenes at the BRC

This year’s winners of our BRC Youth Awards, part of the IoPPN Youth Awards, have completed two days of work experience with leading clinicians, scientists and researchers at our Denmark Hill campus.

By Administrator at 28 Aug 2019

Close monitoring essential to ensure safety of ketamine for depression

Patients, carers and advocates say better evidence is needed on the safety of ketamine for depression after long-term use, and that those prescribed it must be closely monitored. These are the results of a study undertaken as part of a collaboration between the NIHR Maudsley Biomedical Research Centre (BRC) and NIHR Oxford Health Biomedical Research Centre (BRC). 

 

By Administrator at 30 Jul 2019